Lifeline: Joan Armstrong, 82, has been refused funding for the ... Aug 27, 2008
Wet age-related macular degeneration is the leading cause of blindness. But previously, the National Institute for Health and Clinical Excellence suggested that the drug Lucentis should only be given to those already blind in one eye. (Daily Mail)
Block that blue light Aug 20, 2008
Luteins role in protecting the eyes from age-related macular degeneration begins at birth ... This is known as age-related macular degeneration (AMD) and affects those aged 60 and above. (The Star Online, Malaysia)
Senior notes Aug 15, 2008
Adaptive Technology/Perkins Products hosts a free hands-on seminar, Living Well with Age-related Macular Degeneration, at Perkins School for the Blind, 175 North Beacon St., Watertown, on Saturday, Sept. 20, 8:30 a.m.-12:30 p.m.. Dr. Mary Lou Jackson, director of Massachusetts Eye & Ear Infirmary, will speak along with staff from Perkins Strategies for Life/Outreach 55+ and The Braille & Talking Books Library. (Watertown TAB & Press, MA)
Some Obese Individuals Appear 'Metabolically Healthy,' Without Increased Cardiovascular Risk Aug 13, 2008
9, 2007) The interplay between genetic predisposition and exposure to modifiable risk factors can multiply the risk for age-related macular degeneration, according to a report in the January issue of Archives. (Oct. (Science Daily)
Levels Of C-reactive Protein In The Blood Do Not Cause Diabetes Aug 13, 2008
10, 2007) High blood levels of C-reactive protein, a substance linked to inflammation, appear to be associated with an increased risk for age-related macular degeneration, according to a new. (Aug. (Science Daily)
Eye health is important! Aug 12, 2008
As adults age the eyes are more susceptible to Age-Related Macular Degeneration (AMD); a progressive eye disease which attacks the macula of the eye where sharpest vision occurs. A healthy lifestyle, no smoking, a healthy diet and protecting the eyes from harmful UV rays are recommended preventative methods to minimise the risk of AMD.. (iAfrica.com)
Consuming Oily Fish May Protect Eyesight in the Elderly Aug 11, 2008
According to the National Eye Institute, age-related macular degeneration is of two types, wet AMD and dry AMD. The dry form is more common and can progress to wet AMD later on ... Age-Related Macular Degeneration or AMD is the leading cause of blindness in people aged over 55 in the United States ... Age-related macular degeneration usually affects elderly people. (News Locale)
Eat oily fish weekly to protect eyesight Aug 9, 2008
WASHINGTON: Eating oily fish once a week may reduce age-related macular degeneration which is the major cause of blindness and poor vision in adults in western countries and the third highest cause of global blindness, according to a study. There are two types of age-related macular dengeneration (AMD), wet and dry. (Economic Times)
MHS alum sets his sites on sight: Drug helps people losing their eyesight (2) Aug 4, 2008
Dr. Robert L. Steinmetz, a 1974 Muscatine High School graduate, was one of the national researchers who tested the effectiveness of a promising new drug for the treatment of age-related macular degeneration (AMD) earlier this year. The eye surgeon has done extensive international research and teaching, and now lives in Tallahassee, Fla. (Muscatine Journal, IO)
Modified Salmonella Slows Tumor Growth Jul 31, 2008
3, 1999) Investigators at Washington University School of Medicine in St. Louis have found that a mechanism key to immune-privilege in the eye also plays a role in age-related macular degeneration, the. . (Science Daily)
DeKalb team tops in Chicago Vision Walk Jul 30, 2008
The goal of the event is to raise funds and awareness for the foundation, the leading non-government organization in the world providing money for research to find preventions, treatments and cures for all forms of retinal degenerative diseases, including age-related macular degeneration the leading cause of blindness in people over age 55. The event raised just under 240,000. (DeKalb Daily Chronicle, IL)
QLT announces second quarter results for 2008 Jul 29, 2008
The drop in Visudyne sales was primarily due to the approval and reimbursement in Europe of alternative therapeutics for age-related macular degeneration. However, Visudyne's sales for the second quarter increased 11. (Canada Newswire)
Japanese Diet Rich In Fish May Hold Secret To Healthy Heart: Omega-3 Fatty Acids From Fish Appear To Prevent Clogged Arteries Jul 29, 2008
ScienceDaily (July 29, 2008) If you're fishing for ways to reduce the risk of heart disease, you might start with the seafood-rich diet typically served up in Japan. According to new research, a lifetime of eating tuna, sardines, salmon and other fish appears to protect Japanese men against clogged arteries, despite other cardiovascular risk factors. (Science Daily)
What is an Amsler Grid? Jul 28, 2008
Macular Degeneration is a normal part of the aging process, but can be caused by things other than aging and in young people, as well as those who have added more birthdays The doctor may refer to ARMD, or AMD, which stands for Age Related Macular Degeneration. If your doctor determines that you have macular degeneration, he will probably send you home with your own Amsler Grid and have you monitor your vision. (Suite101.com)
What is Cystoid Macular Edema? Jul 27, 2008
Age-related Macular Degeneration (): ARMD occurs in two forms: exudative (wet) or atrophic (dry). The exudative form, if untreated, can cause detachment of the retina overlying the macula and resultant CME.. (Suite101.com)
Scientists offer new hope for blind Jul 27, 2008
It identifies people who are genetically at risk of age-related macular degeneration (AMD). The disease damages the retina and can be arrested but not reversed. (Mirror.co.uk)
Boost To Halt Blind Disease Jul 26, 2008
Age-related macular degeneration - or AMD - affects 250,000 people in the UK. It damages the central part of the retina and leaves one in 10 sufferers blind. The test identifies those who are genetically predisposed to the condition, allowing early treatment that can prevent blindness. (Glasgow Daily Record)
Blindness In Old Age May Be Triggered By Hyperactive Immune Resistance Jul 25, 2008
ScienceDaily (July 25, 2008) Age-dependent macular degeneration (AMD) is the commonest cause of blindness in the western industrialised nations. Hereditary changes in the regulation of the immune system influence the risk of contracting AMD.. (Science Daily)
Telescope embedded in glasses lens promises to make driving easier for visually impaired Jul 25, 2008
Says Peli, "The short height of the actual magnifier, its position, and inclusion of a small tilt of the last flat mirror (the one closest to the user's eye), enables the wearer to simultaneously view the magnified field above the unmagnified view of the uninterrupted horizontal field. Not only will the new glasses improve the cosmetics and usefulness of this type of device, the in-the-lens design will make it possible to mass-produce the telescopic magnifier as a standard spectacle lens blank... (EurekAlert!)
Pensioners win treatment after court battle for sight-saving drug Jul 23, 2008
Jean Middleton, 78, from Kingsbury, Raymond Liggins, 76, from Nuneaton, and Patricia Meadows, 65, from Stratford-on-Avon went to the high court because Warwickshire PCT said it could not afford the cost of a new drug, Lucentis, which can prevent blindness from age-related macular degeneration. A course of treatment over two years costs about 10,700 per eye per patient. (guardian.co.uk)
Trials for 'bionic' eye implants Jul 20, 2008
5 million people worldwide have retinitis pigmentosa, and one in 10 people over the age of 55 have age-related macular degeneration. Both diseases cause the retinal cells which process light at the back of the eye to gradually die. (Yahoo News -- Disabilities and the Disabled)
Protein Transports Nutrients Believed To Protect Against Eye Disease Jul 19, 2008
ScienceDaily (July 18, 2008) Scientists have identified the protein responsible for transporting nutrients to the eye that are believed to protect against the development of age-related macular degeneration, a leading cause of vision loss in elderly Americans ... An estimated 10 million Americans have age-related macular degeneration, which gradually destroys sharp, central vision ... 14, 2007) Consuming higher levels of the yellow plant pigments lutein and zeaxanthin may be associated with a... (Science Daily)
Eye Test Could Spot Diabetes Vision Trouble Early Jul 17, 2008
"Diabetes is the best example of that because of the prevalence of the disease in our population. But the technique is also capable of screening other diseases such as glaucoma or age-related macular degeneration," he added. Elner has a financial interest in this technology, and started a company to make it commercially available. (MEDLINEplus)
Visual Impairment May Be Associated With Higher Suicide Risk Jul 16, 2008
(July 12, 2007) Individuals age 49 and older with cataract and those age 49 to 74 years with age-related macular degeneration appear to have higher mortality rates over an 11-year period than those without such. (Oct. (Science Daily)
Retinal transplant boosts vision Jul 14, 2008
The retinal cells, taken from aborted foetuses, were implanted into 10 people with retinitis pigmentosa and age-related macular degeneration ... Retinitis pigmentosa and age-related macular degeneration (AMD) are the most common causes of blindness in old age, and involve the gradual and normally irreversible destruction of the cells on the eye's retina which receive light. (BBC News -- Health)
Sight-drug battle in High Court Jul 13, 2008
The judicial review follows a decision by Warwickshire Primary Care Trust not to fund the drug for people with age-related macular degeneration (AMD). Success for the trio could mean more patients in England being able to have the drug, Lucentis, said the RNIB.. (BBC News -- UK)
Regeneron paying $12.45M settlement Jul 4, 2008
Regeneron is developing protein-based pharmaceuticals for treatment of diseases ranging from age-related macular degeneration to cancer and inflammatory diseases. OTHER STORIES. (Albany Times Union)
New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of Cancers Jul 1, 2008
Lodamin may also be useful in other diseases that involve aberrant blood-vessel growth, such as age-related macular degeneration and arthritis. Developed by Ofra Benny, PhD, in the Children s laboratory of the late Judah Folkman, MD, Lodamin is a novel slow-release reformulation of TNP-470, a drug developed nearly two decades ago by Donald Ingber, MD, PhD, then a fellow in Folkman s lab, and one of the first angiogenesis inhibitors to undergo clinical testing. (Science Daily)
Food pairings: Working for or against you? Jul 1, 2008
So add a little extra-virgin olive oil to your zucchini, spinach, and other dark green vegetables to unleash the carotenoid lutein, an antioxidant that may help protect against age-related macular degeneration. And instead of using fat-free dressing on your salad, drizzle on an olive oil--based one. (CNN -- Health)
Next-generation artificial retina focuses on clinical trials Jul 1, 2008
(It only works for patients whose retina has degenerated, but still have intact nerves connecting to the brain--a condition brought on the disease retinitis pigmentosa and by age-related macular degeneration. The artificial retina has an array of electrodes that stimulates optic nerve cells, sending an image to the brain's vision centers. (EETimes)
Accidental fungus leads to promising cancer drug Jun 30, 2008
The researchers believe lodamin may also be useful in other diseases marked by abnormal blood vessel growth, such as age-related macular degeneration. (Editing by Todd Eastham). (Scientific American)
Omega-3 Foods May Lower Eye Disease Risk Jun 17, 2008
FRIDAY, June 13 (HealthDay News) -- Consuming fish and other foods that contain omega-3 fatty acids may reduce the risk of age-related macular degeneration (AMD), the leading cause of severe vision loss in elderly people. Australian researchers reviewed nine published studies that included a total of 88,974 participants, including 3,203 people with AMD. The combined findings from the studies suggest that a high dietary intake of omega-3 fatty acids is associated with a 38 percent reduced risk of... (MEDLINEplus)
Not until 'Suzy says so' (2) Jun 15, 2008
I'm certain that astaxanthin can improve cataracts and age-related macular degeneration because it's a carotenoid too. It's fascinating that the nutrient slips through the doorway of ALL your cells, even your brain cells. (Lodi News Sentinel, CA)
Eating Fatty Fish Can Help Aging Eyes Jun 13, 2008
Study Shows Diet Rich in Omega-3s Helps Prevent Age-Related Macular Degeneration By WebMD Health News Reviewed by ... Age-related macular degeneration (AMD) occurs when the central part of the retina, called the macula, begins to deteriorate ... Researchers analyzed nine studies that included 88,974 people; 3,203 of those participants had age-related macular degeneration. (WebMD)
Eating Fish And Foods With Omega-3 Fatty Acids Linked To Lower Risk Of Age-related Eye Disease Jun 12, 2008
11, 2008) Eating fish and other foods high in omega-3 fatty acids is associated with reduced risk of the eye disease age-related macular degeneration (AMD), according to a meta-analysis of nine previously published studies ... "Age-related macular degeneration (AMD) is the leading cause of severe vision loss among elderly people," they write as background information in the article ... Dietary {omega}-3 Fatty Acid and Fish Intake in the Primary Prevention of Age-Related Macular Degeneration: A... (Science Daily)
Diets that eat away at illnesses Jun 12, 2008
The group has found that controlling spikes in blood sugar can result in diminished risk for age-related macular degeneration and cataracts. This benefit is achieved with dietary measures as simple as replacing white bread and pasta with whole grain breads and pastas, and by limiting sweet foods or drinks. (Racine Journal Times, WI)
Oily fish 'cuts eye disease risk' Jun 11, 2008
The Annals of Ophthalmology review suggests omega-3 may cut the risk of age-related macular degeneration (AMD) by a third. However, the Australian researchers stop short of encouraging everyone to eat more omega-3 for this reason alone. (BBC News -- Health)
Vitamins Help Prevent Vision Loss From AMD -- If Used Correctly Jun 7, 2008
6, 2008) A study of individuals with age-related macular degeneration (AMD), based at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, found that nearly 40 percent of those likely to benefit from specific vitamin/mineral supplements were either not taking the supplements or not using the recommended dosage ... 11, 2003) If every American at risk for advanced age-related macular degeneration (AMD) took daily supplements of antioxidant vitamins and zinc, more than 300,000... (Science Daily)
Vitamins to prevent vision loss Jun 3, 2008
WASHINGTON: A new study of people with age-related macular degeneration (AMD), based at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, has found that a correct usage of vitamin supplements may help prevent loss of vision in those suffering from AMD.. However, they discovered that a majority of patients lack a clear understanding of supplement use in AMD treatment. (India Times, India)
ThromboGenics and BioInvent Report Positive Phase I Results for Anti-PlGF Cancer Therapeutic TB-403 Jun 3, 2008
ThromboGenics and BioInvent also intend to develop TB-403 for eye diseases, to block uncontrolled blood vessel growth in conditions such as age-related macular degeneration (AMD) and diabetic retinopathy. About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. (PR Newswire)
New Treatments For Viral And Other Diseases By Blocking Genes May 28, 2008
"Three clinical trials are ongoing to treat patients with age-related macular degeneration. Furthermore, one talk at the conferences was about the use of RNAi against cancer. A clinical trial for that was announced to begin at the end of 2008," said Kurreck. Adapted from materials provided by. (Science Daily)
New Drug Reduces One Cause Of Vision Loss May 20, 2008
18, 2005) A new drug for treatment of the wet form of age-related macular degeneration, known as AMD, has been approved by the FDA recently ... 19, 2000) Photodynamic therapy (PDT), a treatment for age-related macular degeneration under study at Emory University and other sites, has received Food and Drug Administration (FDA) approval. (Science Daily)
Vision for the future May 17, 2008
They meet at Wolfe Eye Clinic so he can treat Welch's age-related macular degeneration with Lucentis, a recently approved injectable drug that prevents further loss of Welch's eyesight ... Age-related macular degeneration is the leading cause of vision loss in people over 60. (Mid Iowa Enterprise, IA)
Quinoa, the new ancient super food May 15, 2008
According to WebMD, spinach is "The best food on the planet to prevent cataracts and age-related macular degeneration, thus ensuring a lifetime of good vision." Moms have been telling us that for generations. Americans were latecomers to soy and yogurt but with the aid of the Wall Street ad man we finally got the message and it's on every grocery shelf. (Seacoast New Hampshire)
Vision Therapy Appears To Improve Visual Function In Macular Disease May 14, 2008
19, 2000) Photodynamic therapy (PDT), a treatment for age-related macular degeneration under study at Emory University and other sites, has received Food and Drug Administration (FDA) approval ... 30, 2007) A computer-based method for evaluating the eye's ability to distinguish object details and shape in patients with age-related macular degeneration could provide a more accurate way to assess the. (Science Daily)
Genaera cutting jobs, bonuses and executive pay May 10, 2008
Last year the company abandoned development of what had been its lead drug candidate, Evizon, which was a treatment for wet age related macular degeneration, the leading cause of legal blindness among adults 50 or older in the Western world. Armstrong said at the time that preliminary information from a clinical study suggested that Evizon was unlikely to produce vision improvement necessary to compete with recently introduced treatments. (Philadelphia Business Journal, PA)
Novadaq's OPTTX System Data Presented at ARVO May 9, 2008
Sacco Hospital in Milan Italy and University Hospital of Coventry in Coventry, England are using OPTTX routinely in the evaluation and treatment of patients with wet Age-related macular degeneration (AMD) ... Novadaq also offers the OPTTX System, which leverages the company's core imaging technology and is designed for the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD). (Canada Newswire)
Cell's 'Power Plant' Genes Raise Vision Disorder Risk May 9, 2008
ScienceDaily (May 8, 2008) Genetic variation in the DNA of mitochondria -- the "power plants" of cells -- contributes to a person's risk of developing age-related macular degeneration (AMD), Vanderbilt investigators report May 7 in the journal PLoS One ... 4, 2008) Scientists have identified a new genetic risk factor for age-related macular degeneration (AMD), a major cause of untreatable blindness in elderly people in developed countries ... 2, 2008) A new study of age-related macular... (Science Daily)
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration May 8, 2008
International Study to Evaluate Efficacy and Safety in Treating a Leading Cause of Blindness LEVERKUSEN, Germany, MONTVILLE, New Jersey and TARRYTOWN, New York, May 8 /PRNewswire-FirstCall/ -- Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (NASDAQ: ) today announced that the first patient has been dosed in the VIEW 2 trial, a second Phase 3 clinical study in a development program evaluating VEGF Trap-Eye for the treatment of the neovascular form of Age-related Macular Degeneration (wet... (PR Newswire)
Bayer and Regeneron Dose First Patient in Second Phase ... May 8, 2008
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration ... Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration ... LEVERKUSEN, Germany, MONTVILLE, New Jersey and TARRYTOWN, New York, May 8, 2008 /PRNewswire-FirstCall via COMTEX News Network/ ----Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the first patient has been... (Fox News)
Bayer, Regeneron start additional phase III study on VEGF Trap-Eye May 8, 2008
FRANKFURT (Thomson Financial) - Bayer AG. said it started a second phase III study of the VEGF Trap-Eye injection it is developing with Regeneron Pharmaceuticals Inc. as a treatment of the neovascular form of age-related macular degeneration (wet AMD). As part of the study, Bayer (nyse: - - ) will enrol about 1,200 patients in Europe, Asia Pacific, Japan and Latin America, the German drug maker said in a statement. (Forbes -- Markets)
Take care of your eyes May 7, 2008
Smoking exposes your eyes to high levels of oxidative stress, and it's known that smoking increases your risk of developing age-related macular degeneration (AMD). The macular area of the retina has the finest blood supply in the body, serving the retinal receptors that enable us to see minute details clearly. (iAfrica.com)
QLT completes enrollment in the RADICAL study May 5, 2008
"We look forward to reporting interim results in the fourth quarter of 2008 and top-line results in the first half of 2009." The RADICAL trial is a Phase II, multicenter, randomized, single-masked study comparing reduced-fluence Visudyne-Lucentis combination therapies and Lucentis monotherapy in subjects with choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) ... Visudyne (verteporfin for injection) therapy is indicated for the treatment of patients with... (Canada Newswire)
XOMA to Announce First Quarter 2008 Financial Results and Host Conference Call on Monday, May 12 May 5, 2008
XOMA's technologies and experienced team have contributed to the success of marketed antibody products, including RAPTIVA(r) (efalizumab) for chronic moderate to severe plaque psoriasis and LUCENTIS(r) (ranibizumab injection) for wet age-related macular degeneration. The Company has a premier antibody discovery and development platform that incorporates leading antibody phage display libraries and XOMA's proprietary Human Engineering(tm) and bacterial cell expression technologies. (Primezone Releases)
Hormone Use Related To Lower Risk Of Macular Degeneration In Postmenopausal Women Apr 18, 2008
17, 2008) Women who take postmenopausal hormones appear to have a lower risk of developing advanced stages of the eye disease age-related macular degeneration, especially if they had also taken oral contraceptives in the past, according to a new report ... Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness among older adults, affecting 1 ... 30, 2007) With 8 million people at high risk for advanced age-related macular degeneration, researchers discovered... (Science Daily)
Antioxidant Users Don't Live Longer, Analysis Of Studies Concludes Apr 16, 2008
11, 2007) A diet rich in antioxidant vitamins and minerals does not seem to prevent the degenerative eye disease known as age related macular degeneration. Age related macular degeneration is the leading cause. (Science Daily)
Hormone Replacement May Cut Risk for Age-Linked Eye Disease Apr 16, 2008
MONDAY, April 14 (HealthDay News) -- Postmenopausal women who take hormones have a lower risk of developing advanced age-related macular degeneration, especially if they took oral contraceptives in the past, a U.S. study finds. Age-related macular degeneration (AMD) affects 1. (MEDLINEplus)
Genentech Net Up, Key Drug's Growth Slows Apr 11, 2008
State " Zip: Email: 12 ISSUES FOR $12.00 71% OFF! 24 ISSUES FOR $18.00 79% OFF! 36 ISSUES FOR $24.00 Best Deal! Print Send By Val Brickates Kennedy BOSTON (Dow Jones) -- Genentech Inc. reported a 12% boost in its bottom line late Thursday, largely due to increased sales for its cancer therapies Rituxan, Avastin and Herceptin. Genentech (DNA) posted net income of $790 million for the quarter ended March 31, compared with $706 million for the previous year's quarter. Earnings per share including... (SmartMoney)
Virginia's largest Cardiac Surgery program adopts SPY as standard of care Apr 8, 2008
Novadaq also offers the OPTTX(R) System, which leverages the company's core imaging technology and is designed for the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD). For more information, please visit the company's website at. (Canada Newswire)
Age-Related Eye Disease on the Increase Apr 6, 2008
3 million of the more than 2 million Americans aged 50 and older that have age-related macular degeneration. And, approximately 6 million women and 3 million men have moderate to severe symptoms of dry eye syndrome, a condition caused when not enough natural tears are produced, according to the National Women's Health Resource Center. (Health-Finder)
Read more... Apr 4, 2008
Age-related macular degeneration (AMD) cases rose 25 percent, the largest increase of the major eye diseases. Currently, 2 million Americans have been diagnosed with AMD.. (PNN Online)
New Drug Could Save Sight Of Thousands Apr 2, 2008
The Royal National Institute for the Blind said a treatment of wet age-related macular degeneration - or AMD - is due to be approved by the health watchdog. AMD is the leading cause of sight loss in the UK and destroys the central region of the retina, the macula, leading to progressive loss of sight. (Sky News)
ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III) Apr 1, 2008
Other major eye diseases that may benefit from nonsurgical PVD induction include diabetic retinopathy and age-related macular degeneration (AMD). Diabetic retinopathy is the leading cause of blindness among working-age adults, while AMD is the leading cause of blindness among the elderly. (PR Newswire)
DNA breakthroughs yield results Apr 1, 2008
One involves a leading cause of blindness in older people, age-related macular degeneration. A series of , the most recent in 2005, "led to huge breakthroughs in understanding" that disease, said Stephen Daiger, a Houston scientist. (Globe and Mail)
Indian-American red-flags gene cure Mar 30, 2008
Ambati team's finding arose out of research on mice using siRNA strands designed to tackle age-related macular degeneration (AMD), a form of blindness that strikes late in life and affects 50 million people worldwide. Two US companies are doing advanced trials aimed at fixing AMD by injecting siRNAs into the eye, based on the idea that the molecules enter cells and switch off the flawed gene that causes the problem. (India Times, India -- Health/Science)
